First Light Asset Management, LLC Biomarin Pharmaceutical Inc Transaction History

First Light Asset Management, LLC

$1.1 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $9.52 Million - $12.3 Million	124,925 Added 205.96%	185,579 $17.9 Million
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $71,771 - $83,048	-828 Reduced 1.35%	60,654 $5.26 Million
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $5.22 Million - $6.97 Million	-59,459 Reduced 49.16%	61,482 $5.98 Million
Q4 2022 Feb 14, 2023	SELL	$80.93 - $108.63 $192,694 - $258,648	-2,381 Reduced 1.93%	120,941 $12.5 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $1.52 Million - $1.79 Million	18,509 Added 17.66%	123,322 $10.5 Million
Q2 2022 Aug 12, 2022	BUY	$71.48 - $86.85 $838,531 - $1.02 Million	11,731 Added 12.6%	104,813 $8.69 Million
Q1 2022 May 13, 2022	SELL	$74.28 - $92.69 $2.58 Million - $3.22 Million	-34,703 Reduced 27.16%	93,082 $7.18 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $3.5 Million - $4.46 Million	-48,774 Reduced 27.62%	127,785 $11.3 Million
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $13.2 Million - $15.1 Million	176,559 New	176,559 $13.6 Million
Q3 2020 Nov 13, 2020	SELL	$71.87 - $131.03 $7.42 Million - $13.5 Million	-103,310 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $146,928 - $229,434	-1,847 Reduced 1.76%	103,310 $12.7 Million
Q1 2020 May 15, 2020	BUY	$71.37 - $96.85 $260,286 - $353,211	3,647 Added 3.59%	105,157 $8.89 Million
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $131,239 - $176,367	-2,042 Reduced 1.97%	101,510 $8.58 Million
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $2.26 Million - $2.85 Million	33,475 Added 47.77%	103,552 $6.98 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $354,905 - $414,756	4,417 Added 6.73%	70,077 $6 Million
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $321,728 - $376,827	3,821 Added 6.18%	65,660 $5.83 Million
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $36,784 - $48,686	-459 Reduced 0.74%	61,839 $5.27 Million
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $42,451 - $47,785	-452 Reduced 0.72%	62,298 $6.04 Million
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $2.35 Million - $3.06 Million	30,900 Added 97.02%	62,750 $5.91 Million
Q1 2018 May 15, 2018	BUY	$77.67 - $92.63 $49,475 - $59,005	637 Added 2.04%	31,850 $2.58 Million
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $55,643 - $65,544	-689 Reduced 2.16%	31,213 $2.78 Million
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $27,000 - $31,808	335 Added 1.06%	31,902 $2.97 Million
Q2 2017 Aug 14, 2017	BUY	N/A	31,567	31,567 $2.87 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

Black Rock Inc. New York, NY

22.7M
Shares

$1.6 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$1.34 Billion
0.03% of portfolio
Primecap Management CO Pasadena, CA

18.8M
Shares

$1.33 Billion
1.14% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$983 Million
0.72% of portfolio
Capital Research Global Investors Los Angeles, CA

9.69M
Shares

$684 Million
0.18% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Light Asset Management, LLC with notifications on news.

Account